{"title":"Dr. Mageshwari Rajendran, THAKUR PUBLICATIONS PVT LTD","description":null,"products":[{"product_id":"pharmacological-and-toxicological-screening-methods-i-authors-dr-mageshwari-rajendran-thakur-publications-pvt-ltd","title":"PHARMACOLOGICAL AND TOXICOLOGICAL SCREENING METHODS-I, Authors : Dr. Mageshwari Rajendran, THAKUR PUBLICATIONS PVT LTD","description":"\u003ch1\u003eSyllabus\u003c\/h1\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cb\u003e\u003cspan\u003eMPL 103T: Pharmacological and Toxicological Screening\u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cb\u003e\u003cspan\u003eMethods - I\u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan lang=\"en-in\"\u003e\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan lang=\"en-in\"\u003eTheory\u003cspan\u003e                                                                                                       \u003c\/span\u003e\u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e(60 hours)\u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan lang=\"en-in\"\u003e\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eUnit-1 \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e                                                                                                 \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e(12 hours)\u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e1.\u003cb\u003e \u003c\/b\u003e\u003c\/span\u003e\u003cb\u003e\u003cspan\u003e   \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003eLaboratory Animals\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e        \u003cb\u003eCommon Laboratory Animals:\u003c\/b\u003e Description, handling and applications of different species and strains of animals.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e        \u003cb\u003eTransgenic Animals:\u003c\/b\u003e Production, maintenance and applications Anaesthesia and euthanasia of experimental animals.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e        Maintenance and breeding of laboratory animals\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e        CPCSEA guidelines to conduct experiments on animals\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e        Good Laboratory Practice\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e        \u003cb\u003eBioassay:\u003c\/b\u003e Principle, scope and limitations and methods\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eUnit-2 \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e                                                                                                \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e(12 hours)\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e2.     Preclinical Screening of New Substances for the Pharmacological Activity Using In-vivo, In-vitro, and other possible Animal Alternative Models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e        General Principles of Preclinical Screening. \u003cb\u003eCNS Pharmacology:\u003c\/b\u003e Behavioral and muscle coordination, CNS stimulants and depressants, anxiolytics, anti-psychotics, anti-epileptics and nootropics. Drugs for neurodegenerative diseases like Parkinsonism, Alzheimer’s and multiple sclerosis. Drugs acting on Autonomic Nervous System\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eUnit-3 \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e                                                                                                \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003e(12 hours)\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e3.     Preclinical Screening of New Substances for the Pharmacological Activity Using In-vivo, In-vitro, and other possible Animal Alternative Models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eRespiratory Pharmacology:\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e Anti-asthmatics, drugs for COPD and Anti-allergics. \u003cb\u003eReproductive Pharmacology:\u003c\/b\u003e Aphrodisiacs and Anti-fertility agents, Analgesics, Anti-inflammatory and Anti-pyretic agents.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eGastrointestinal Drugs:\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e Anti-ulcer, Anti-emetic, Anti-diarrheal and Laxatives.\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eUnit-4                                                                                                                                 (12 hours)\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e4.     Preclinical Screening of New Substances for the Pharmacological Activity Using In-vivo, In-vitro, and other possible Animal Alternative Models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eCardiovascular Pharmacology:\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e Anti-hypertensives, Anti-arrythmics, Anti-anginal, Anti-atherosclerotic agents and Diuretics. Drugs for metabolic disorders like Anti-diabetic, Anti-dyslipidemic agents.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003eAnti-cancer agents. Hepatoprotective screening methods\u003c\/span\u003e\u003cb\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eUnit-5                                                                                                                                  (12 hours)\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e5.     Preclinical Screening of New Substances for the Pharmacological Activity Using In-vivo, In-vitro, and other possible Animal Alternative Models.\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003eImmunomodulators, Immunosuppressants and Immunostimulants\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eGeneral Principles of Immunoassay:\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e Theoretical basis and optimization of immunoassay, heterogeneous and homogenous immunoassay systems. Immunoassay methods evaluation; protocol outline, objectives and preparation. Immunoassay for digoxin and insulin\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003eLimitations of animal experimentation and alternate animal experiments\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003eExtrapolation of in-vitro data to preclinical and preclinical to humans\u003c\/span\u003e\u003c\/p\u003e","brand":"New Vidyasagar Book Mart","offers":[{"title":"Default Title","offer_id":53438073667881,"sku":null,"price":300.0,"currency_code":"INR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0867\/4367\/9273\/files\/Screenshot2026-05-28112522.png?v=1787154972"}],"url":"https:\/\/www.onetouchbook.com\/collections\/dr-mageshwari-rajendran-thakur-publications-pvt-ltd.oembed","provider":"OneTouch Book","version":"1.0","type":"link"}